Alnylam Pharmaceuticals
ALNY
#852
Rank
โ‚ฌ26.34 B
Marketcap
196,91ย โ‚ฌ
Share price
1.42%
Change (1 day)
-46.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚ฌ26.34 Billion

As of August 2026 Alnylam Pharmaceuticals has a market cap of โ‚ฌ26.34 Billion. This makes Alnylam Pharmaceuticals the world's 852th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ26.34 B-41.51%
2025โ‚ฌ45.05 B52.74%
2024โ‚ฌ29.49 B35.74%
2023โ‚ฌ21.72 B-20.28%
2022โ‚ฌ27.25 B52.2%
2021โ‚ฌ17.90 B45.88%
2020โ‚ฌ12.27 B6.44%
2019โ‚ฌ11.53 B78.87%
2018โ‚ฌ6.44 B-38.59%
2017โ‚ฌ10.50 B243.79%
2016โ‚ฌ3.05 B-58.31%
2015โ‚ฌ7.32 B18.98%
2014โ‚ฌ6.15 B107.47%
2013โ‚ฌ2.96 B309.81%
2012โ‚ฌ0.72 B170.08%
2011โ‚ฌ0.26 B-14.57%
2010โ‚ฌ0.31 B-39%
2009โ‚ฌ0.51 B-29.77%
2008โ‚ฌ0.73 B-9.78%
2007โ‚ฌ0.81 B35.14%
2006โ‚ฌ0.60 B176.3%
2005โ‚ฌ0.21 B104.8%
2004โ‚ฌ0.10 B

End of Day market cap according to different sources

On Aug 13th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚ฌ26.34 Billion
by Nasdaq info icon info icon
โ‚ฌ26.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚ฌ250.02 B 848.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ90.95 B 245.18%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚ฌ71.94 B 173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.68 B-93.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚ฌ0.48 B-98.14%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.90 B-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ36.89 B 40.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ10.45 B-60.33%๐Ÿ‡บ๐Ÿ‡ธ USA